AD specific markers such as Amyloid Beta (Aβ) 40, Aβ 40, tau and neurofilament light chain (NfL) have been increasingly explored both in blood and CSF for their utility in detecting AD and PD as well as distinguishing between neurodegenerative conditions [29–35]. This evidence concerns the gene MAPT and Alzheimer disease.